Mar 13, 2026

Healthcare companies are advancing innovation in fields such as drug development and digital health. According to a report from Yahoo Finance, shareholders in the sector have recently seen returns that closely matched broader market performance over a recent six-month period.

Investors are advised to remain cautious, however, due to the significant regulatory oversight affecting many businesses in the industry, which can impact earnings. The analysis highlights two healthcare stocks with potential for sustained outperformance and identifies one company facing challenges.

One Healthcare Stock Facing Headwinds

Haemonetics, with a market capitalization of $2.76 billion, provides…